Search

everythinglearnresearchcommunity

for

Search:↓

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Evening primrose oil significantly improves hormone levels and reduces BMI and cholesterol in women with PCOS.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

Early NAS level changes affect alcohol consumption vulnerability.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Minoxidil and finasteride effectively treat hair loss.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.